CIK 0001514946 · Non-accelerated filer<br>Smaller reporting company
AXIM BIOTECHNOLOGIES, INC.
Sign in to watch- Ticker
- AXIM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 274092986
- Phone
- (212) 751-0001
- Business address
- 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO, CA, 92121
- Former names
- AXIM INTERNATIONAL INC.
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 6,000,000 shares
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 3,861,004 shares at $0.03 ($100,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Conversion Director acquired 854,012 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 5/A Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award President acquired 125,000 shares (grant or award)
Page 2 of 3 · 53 filings